ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2503

IL-17+ CD8+ T Cells Are Enriched In The Joints Of Patients With Psoriatic Arthritis and Correlate With Markers Of Disease Activity and Joint Damage Progression

Bina Menon1,2, Nicola J. Gullick3, Hayley G. Evans4, Gina J. Walter4, Megha Rajasekhar4, Toby Garrood2, Leonie S. Taams4 and Bruce W. Kirkham2, 1Centre for Cellular and Molecular Biology of Inflammation, King's College London, London, United Kingdom, 2Rheumatology, Guy's and St. Thomas' Foundation Hospital NHS Trust, London, United Kingdom, 3Rheumatology, King's College Hospital Foundation NHS Trust, London, United Kingdom, 4Centre for Molecular and Cellular Biology of Inflammation, King's College London, London, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: interleukins (IL), psoriatic arthritis and ultrasonography, T cells

  • Tweet
  • Email
  • Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis: Pathogenesis, Etiology, Animal Models II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Psoriatic arthritis (PsA) and rheumatoid arthritis (RA) have clear differences in clinical, radiological and genetic features, suggesting that the immunopathology of the conditions may also differ. IL-17/Th17 cells are thought to contribute to inflammatory arthritis as well as psoriasis. Given the strong association between MHC class I and PsA, we hypothesized that IL-17+ CD8+ T cells are enriched in PsA and correlate with disease activity and synovitis.

Methods:

Mononuclear cells from synovial fluid (SF) and peripheral blood (PB) compartments from 21 patients with PsA, 14 patients with RA and 14 healthy controls (PB only) were isolated and stimulated for three hours in vitro with PMA and ionomycin in the presence of GolgiStop. CD3+ T cells were investigated for expression of IL-17A by flow cytometry. Clinical measures and Power Doppler Ultrasound (PDUS) of the affected joint were assessed at the time of joint aspiration. PsA subjects were assessed by a blinded observer for erosive changes in hand and feet radiographs.

Results:

Both patients with PsA and RA had a significant increase in IL-17+ CD4+ T cells in the synovial fluid compared to their peripheral blood.  Notably, we also found a significant increase in IL-17 expressing cells in the CD4- compartment in SF from patients with PsA (SF vs. PB, median (IQR)%, 1.10 (0.46-2.29) vs. 0.18 (0.09-0.32), p=0.0002)) whilst this population was virtually absent in SF from patients with RA (p=0.83). The IL-17+ CD4- cells consisted predominantly of CD8+ T cells. No significant differences were found between IL-17+ T cell frequencies from the blood in patients with PsA vs. HC. SF IL-17+ CD4-(CD8+) T cells correlated significantly (Spearman’s r) with CRP (r= 0.57, p=0.005), ESR (r=0.62, p=0.002) as well as PDUS score of the affected joint (n=16, r=0.49, p=0.05), whilst SF IL-17+ CD4+ T cell frequency correlated only with ESR (r=0.42, p=0.05). Interestingly, patients with erosive disease (n=13) had elevated levels of IL-17+ CD3+CD4-(CD8+) cell frequencies in SF vs. non erosive subjects (n=8) (1.91 (1.03-4.94) vs. 0.32 (0.11-1.12), p<0.05, One-way ANOVA, post test: Dunn’s).  IL-17+ CD8+ T cells expressed low levels of perforin, granzyme B and CD107a in PB and SF (n=3) when compared to IFNγ+ CD8+ T cells, indicating that these cells may have a different effector function than cytotoxic CD8+ T cells.

Conclusion:

This is the first report documenting elevated IL-17+ CD3+CD4-(CD8+) cell frequencies in the PsA SF compartment with strong correlates with clinical and imaging measures of disease activity. We propose that IL-17+ CD8+ T cells may be a hitherto unrecognised population in PsA that may contribute to the immunopathology of this disease.


Disclosure:

B. Menon,
None;

N. J. Gullick,
None;

H. G. Evans,
None;

G. J. Walter,
None;

M. Rajasekhar,
None;

T. Garrood,
None;

L. S. Taams,
None;

B. W. Kirkham,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-17-cd8-t-cells-are-enriched-in-the-joints-of-patients-with-psoriatic-arthritis-and-correlate-with-markers-of-disease-activity-and-joint-damage-progression/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology